In a regulatory filing, Lantheus (LNTH) dislcosed that Jeff Humphrey, MD, is no longer Chief Medical Officer at Lantheus Holdings. His last day of employment with the company will be January 3, 2025. Dr. Humphrey’s departure is not due to a disagreement with the company or its Board or management on any matter relating to the company’s operations, clinical programs, policies or practices. A search is underway for his replacement. Brian Markison, CEO, and Paul Blanchfield, President, have assumed interim leadership of research and development.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH: